Philip Mease

Title: The Innovations of Philip Mease

Introduction

Philip Mease is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of biotechnology, particularly in the treatment of rheumatoid arthritis. His work focuses on developing methods that enhance the efficacy of TNF-α inhibitors.

Latest Patents

Philip Mease holds a patent for "Methods for determining efficacy of TNF-α inhibitors for treatment of rheumatoid arthritis." This invention provides methods, uses, and compositions for treating rheumatoid arthritis. It describes how a TNF-α inhibitor, such as a human TNF-α antibody or its antigen-binding portion, can be utilized effectively. Additionally, the patent outlines methods for determining the efficacy of these inhibitors in treating rheumatoid arthritis in subjects.

Career Highlights

Philip Mease is associated with AbbVie Biotechnology Ltd., where he continues to innovate in the field of medical treatments. His work has been instrumental in advancing therapeutic options for patients suffering from rheumatoid arthritis.

Collaborations

Some of his notable coworkers include Hartmut Kupper and Jeffrey Kent. Their collaborative efforts contribute to the ongoing research and development in the biotechnology sector.

Conclusion

Philip Mease's contributions to the field of biotechnology, particularly through his patent on TNF-α inhibitors, highlight his role as an influential inventor. His work continues to impact the treatment of rheumatoid arthritis, showcasing the importance of innovation in medical science.